Jodantipyrin - first tabletted antivirial agent for treatment and prevention of tick-borne encephalitis and HFRS
Jodantipyrin - first tabletted antivirial agent for treatment and prevention of tick-borne encephalitis and HFRS
FAQ
Русский
   :: Jodantipyrin


  
 
 Энцефалит.ру -
все о клещевом
энцефалите,
клещевом боррелиозе
и других инфекциях
передаваемых
клещами.
 
Эксклюзивные товары
 
 
Pharmacologic properties
Anti - inflammatory effect
Improve immunity
High antiviral activity
Mobilize body defences
Block penetration of the virus into the cell
Considerably lower in cost than immunogllobulin
Indications
 
Tick - borne encephalitis
Hemorrhagic Fever with Kidney syndrome
Influenza and other acute viral respiratory infections
Genital condylomatosis

Expiry Date 2 years
28.04.2009 || Official letters

Official letters to the international organizations WHO and CDC regarding swine flu

Copyright (c) 2001 OOO NTM - science, technics, medicine - producer and supplier of the agent Power by Media-com